Viswajit Kandula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Viswajit Kandula has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Chitaru Kurihara
Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
3 shared publications - Adwaiy Manerikar
Department of Thoracic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
2 shared publications - Jonathan D. Boucher
Center for Synthetic Biology, Northwestern University, Evanston, IL, 60208, USA
2 shared publications - Joseph J. Muldoon
University of California, San Francisco 1 Department of Medicine San Francisco, California
2 shared publications - Joshua Nathaniel Leonard
Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois 60208, United States
2 shared publications - Mihe Hong
Department of Chemical and Biomolecular Engineering, University of California-Los Angeles, Los Angeles, CA 90095, USA
2 shared publications
Latest Publications
- Open Access
- 24 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6761
Redefining Aortic Valve Replacement: The Transition from Open Surgery to Transcatheter Innovation
Aortic valve replacement (AVR) has evolved dramatically, transitioning from open surgery to minimally invasive and transcatheter approaches. This review examines the historical and technological advancements in AVR, focusing on the evolution of mechanical and bioprosthetic valves, valve-sparing techniques, and the Ross procedure. Mechanical valves offer superior durability but require lifelong anticoagulation, while bioprosthetic valves avoid this need at the expense of long-term durability. Transcatheter aortic valve replacement (TAVR), originally reserved for high-risk patients, is now used across all risk profiles due to growing evidence of safety and efficacy from major trials like PARTNER and Core Valve. Despite its benefits, TAVR presents some challenges, including paravalvular leak, pacemaker implantation, and uncertain long-term durability, especially in younger patients. Valve-in-valve techniques, novel valve designs, and anti-calcification treatments offer promising solutions. Looking forward, the integration of artificial intelligence and personalized procedural planning will play a key role in optimizing outcomes. As AVR technology advances, careful patient selection and a multidisciplinary approach remain essential to guiding individualized treatment decisions.
- 24 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6761
Open AccessRedefining Aortic Valve Replacement: The Transition from Open Surgery to Transcatheter Innovation
Aortic valve replacement (AVR) has evolved dramatically, transitioning from open surgery to minimally invasive and transcatheter approaches. This review examines the historical and technological advancements in AVR, focusing on the evolution of mechanical and bioprosthetic valves, valve-sparing techniques, and the Ross procedure. Mechanical valves offer superior durability but require lifelong anticoagulation, while bioprosthetic valves avoid this need at the expense of long-term durability. Transcatheter aortic valve replacement (TAVR), originally reserved for high-risk patients, is now used across all risk profiles due to growing evidence of safety and efficacy from major trials like PARTNER and Core Valve. Despite its benefits, TAVR presents some challenges, including paravalvular leak, pacemaker implantation, and uncertain long-term durability, especially in younger patients. Valve-in-valve techniques, novel valve designs, and anti-calcification treatments offer promising solutions. Looking forward, the integration of artificial intelligence and personalized procedural planning will play a key role in optimizing outcomes. As AVR technology advances, careful patient selection and a multidisciplinary approach remain essential to guiding individualized treatment decisions.
- Open Access
- 1 May 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (5) , 3522-3524
Striking a balance when operating for acute type A aortic dissection
Striking a balance when operating for acute type A aortic dissection
- 1 May 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (5) , 3522-3524
Open AccessStriking a balance when operating for acute type A aortic dissection
Striking a balance when operating for acute type A aortic dissection
- Open Access
- 16 November 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (4) , 577-590
Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts
- 16 November 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (4) , 577-590
Open AccessTemporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts
- 1 June 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (6) , 859-864
Indwelling Central Venous Catheters Drive Bloodstream Infection During Veno-venous Extracorporeal Membrane Oxygenation Support
Blood stream infection (BSI) is a potentially lethal complication in patients receiving extracorporeal membrane oxygenation (ECMO). It may be particularly common in patients with veno-venous ECMO due to their long hospitalization in the intensive care unit. Given that these patients have concurrent indwelling central venous catheters (CVC), it is unclear whether the ECMO circuit, CVC, or both, contribute to BSI. This study evaluated the risk factors associated with BSI in patients receiving veno-venous ECMO in a single institution study of 61 patients from 2016 through 2019. All ECMO catheters and the circuit oxygenator fluid were aseptically collected and analyzed for microorganisms at the time of decannulation. New BSI was diagnosed in 15 (24.6%) patients and increased mortality by threefold. None of the ECMO catheters or oxygenator fluid were culture positive. BSI increased with CVC use of over 8 days and was significantly lowered when CVC were exchanged by day 8 compared with patients with exchanges at later points (15.0% vs. 42.8%, p = 0.02). Median length of CVC use in the BSI-negative and BSI-positive group were 6.3 ± 5.0 and 9.4 ± 5.1, respectively (p = 0.04). In summary, BSI is a potentially lethal complication in patients receiving ECMO. Indwelling CVC, not the ECMO circuitry, is the likely contributor for BSI, and exchanging CVC by day 8 can reduce the incidence of BSI.
- 1 June 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (6) , 859-864
Indwelling Central Venous Catheters Drive Bloodstream Infection During Veno-venous Extracorporeal Membrane Oxygenation Support
Blood stream infection (BSI) is a potentially lethal complication in patients receiving extracorporeal membrane oxygenation (ECMO). It may be particularly common in patients with veno-venous ECMO due to their long hospitalization in the intensive care unit. Given that these patients have concurrent indwelling central venous catheters (CVC), it is unclear whether the ECMO circuit, CVC, or both, contribute to BSI. This study evaluated the risk factors associated with BSI in patients receiving veno-venous ECMO in a single institution study of 61 patients from 2016 through 2019. All ECMO catheters and the circuit oxygenator fluid were aseptically collected and analyzed for microorganisms at the time of decannulation. New BSI was diagnosed in 15 (24.6%) patients and increased mortality by threefold. None of the ECMO catheters or oxygenator fluid were culture positive. BSI increased with CVC use of over 8 days and was significantly lowered when CVC were exchanged by day 8 compared with patients with exchanges at later points (15.0% vs. 42.8%, p = 0.02). Median length of CVC use in the BSI-negative and BSI-positive group were 6.3 ± 5.0 and 9.4 ± 5.1, respectively (p = 0.04). In summary, BSI is a potentially lethal complication in patients receiving ECMO. Indwelling CVC, not the ECMO circuitry, is the likely contributor for BSI, and exchanging CVC by day 8 can reduce the incidence of BSI.
- Open Access
- 7 April 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (4) , S293
Recipient, Surgical, and Donor Factors Leading to Primary Graft Dysfunction Following Lung Transplantation
- 7 April 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (4) , S293
Open AccessRecipient, Surgical, and Donor Factors Leading to Primary Graft Dysfunction Following Lung Transplantation
- 24 April 2021
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 33 (3) , 325-332
Does gender bias affect outcomes in mitral valve surgery for degenerative mitral regurgitation?
: OBJECTIVES: This study was conducted to determine if gender bias explains the worse outcomes in women than in men who undergo mitral valve surgery for degenerative mitral regurgitation. METHODS: Patients who underwent mitral valve surgery for degenerative mitral regurgitation with or without concomitant ablation surgery for atrial fibrillation were identified from the Cardiovascular Research Database of the Clinical Trial Unit of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital and were defined according to the Society of Thoracic Surgery National Adult Cardiac Surgery Database. Of the 1004 patients (33% female, mean age 62.1 ± 12.4 years; 67% male, mean age 60.1 ± 12.4 years) who met this criteria, propensity score matching was utilized to compare sex-related differences. RESULTS: Propensity score matching of 540 patients (270 females, mean age 61.0 ± 12.2; 270 males, mean age 60.9 ± 12.3) demonstrated that 98% of mitral valve surgery performed in both groups was mitral valve repair and 2% was mitral valve replacement. Preoperative CHA2DS2-VASc scores were higher in women and fewer women were discharged directly to their homes. Before surgery, women had smaller left heart chambers, lower cardiac outputs, higher diastolic filling pressures and higher volume responsiveness than men. However, preoperative left ventricular and right ventricular strain values, which are normally higher in women, were similar in the 2 groups, indicating worse global strain in women prior to surgery. CONCLUSIONS: The worse outcomes reported in women compared to men undergoing surgery for degenerative mitral regurgitation are misleading and not based on gender bias except in terms of referral patterns. Men and women who present with the same type and degree of mitral valve disease and similar comorbidities receive the same types of surgical procedures and experience similar postoperative outcomes. Speckle-tracking echocardiography to assess global longitudinal strain of the left and right ventricles should be utilized to monitor for myocardial dysfunction related to chronic mitral regurgitation.
- 24 April 2021
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 33 (3) , 325-332
Does gender bias affect outcomes in mitral valve surgery for degenerative mitral regurgitation?
: OBJECTIVES: This study was conducted to determine if gender bias explains the worse outcomes in women than in men who undergo mitral valve surgery for degenerative mitral regurgitation. METHODS: Patients who underwent mitral valve surgery for degenerative mitral regurgitation with or without concomitant ablation surgery for atrial fibrillation were identified from the Cardiovascular Research Database of the Clinical Trial Unit of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital and were defined according to the Society of Thoracic Surgery National Adult Cardiac Surgery Database. Of the 1004 patients (33% female, mean age 62.1 ± 12.4 years; 67% male, mean age 60.1 ± 12.4 years) who met this criteria, propensity score matching was utilized to compare sex-related differences. RESULTS: Propensity score matching of 540 patients (270 females, mean age 61.0 ± 12.2; 270 males, mean age 60.9 ± 12.3) demonstrated that 98% of mitral valve surgery performed in both groups was mitral valve repair and 2% was mitral valve replacement. Preoperative CHA2DS2-VASc scores were higher in women and fewer women were discharged directly to their homes. Before surgery, women had smaller left heart chambers, lower cardiac outputs, higher diastolic filling pressures and higher volume responsiveness than men. However, preoperative left ventricular and right ventricular strain values, which are normally higher in women, were similar in the 2 groups, indicating worse global strain in women prior to surgery. CONCLUSIONS: The worse outcomes reported in women compared to men undergoing surgery for degenerative mitral regurgitation are misleading and not based on gender bias except in terms of referral patterns. Men and women who present with the same type and degree of mitral valve disease and similar comorbidities receive the same types of surgical procedures and experience similar postoperative outcomes. Speckle-tracking echocardiography to assess global longitudinal strain of the left and right ventricles should be utilized to monitor for myocardial dysfunction related to chronic mitral regurgitation.
- Open Access
- 19 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (8) , eabe9375
Model-guided design of mammalian genetic programs
A suite of genetic components and computational models enables the predictive design of mammalian cellular functions.
- 19 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (8) , eabe9375
Open AccessModel-guided design of mammalian genetic programs
A suite of genetic components and computational models enables the predictive design of mammalian cellular functions.
- Open Access
Model-guided design of mammalian genetic programs
Genetically engineering cells to perform customizable functions is an emerging frontier with numerous technological and translational applications. However, it remains challenging to systematically engineer mammalian cells to execute complex functions. To address this need, we developed a method enabling accurate genetic program design using high-performing genetic parts and predictive computational models. We built multi-functional proteins integrating both transcriptional and post-translational control, validated models for describing these mechanisms, implemented digital and analog processing, and effectively linked genetic circuits with sensors for multi-input evaluations. The functional modularity and compositional versatility of these parts enable one to satisfy a given design objective via multiple synonymous programs. Our approach empowers bioengineers to predictively design mammalian cellular functions that perform as expected even at high levels of biological complexity.
Open AccessModel-guided design of mammalian genetic programs
Genetically engineering cells to perform customizable functions is an emerging frontier with numerous technological and translational applications. However, it remains challenging to systematically engineer mammalian cells to execute complex functions. To address this need, we developed a method enabling accurate genetic program design using high-performing genetic parts and predictive computational models. We built multi-functional proteins integrating both transcriptional and post-translational control, validated models for describing these mechanisms, implemented digital and analog processing, and effectively linked genetic circuits with sensors for multi-input evaluations. The functional modularity and compositional versatility of these parts enable one to satisfy a given design objective via multiple synonymous programs. Our approach empowers bioengineers to predictively design mammalian cellular functions that perform as expected even at high levels of biological complexity.